Valid Consent for Genomic Epidemiology in Developing Countries

dc.contributor.authorChokshi, D.A.
dc.contributor.authorThera, M.A.
dc.contributor.authorParker, M.
dc.contributor.authorDiakite, M.
dc.contributor.authorMakani, J.
dc.contributor.authorKwiatkowski, D.P.
dc.contributor.authorDoumbo, O.K.
dc.date.accessioned2013-04-04T12:51:29Z
dc.date.available2013-04-04T12:51:29Z
dc.date.issued2007
dc.description.abstractGenomic research has the potential to improve global health by elucidating basic mechanisms of disease, susceptibility, and resistance, thereby guiding the development of preventive interventions [1]. Recently developed methods for exploring how human genetic variation affects resistance are likely to provide strategic clues about vaccine development for researchers working on malaria, HIV, tuberculosis, and other diseases of the developing worlden_GB
dc.identifier.citationChokshi, D. A., Thera, M. A., Parker, M., Diakite, M., Makani, J., Kwiatkowski, D. P., & Doumbo, O. K. (2007). Valid consent for genomic epidemiology in developing countries. PLoS medicine, 4(4), e95.
dc.identifier.otherdoi:10.1371/journal.pmed.0040095
dc.identifier.urihttp://hdl.handle.net/123456789/783
dc.language.isoenen_GB
dc.publisherPLoS Medicine
dc.relation.ispartofseriesPLoS Medicine 4(4): e95.
dc.subjectValid Consenten_GB
dc.subjectGenomic Epidemiologyen_GB
dc.subjectDeveloping Countriesen_GB
dc.titleValid Consent for Genomic Epidemiology in Developing Countriesen_GB
dc.typeArticleen_GB

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Makani J.pdf
Size:
120.77 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: